Biotech as an Asset Class: Investing Across Human and Planetary Health
This session explores how biotech is evolving within venture capital, from its traditional focus on human health to a broader role in planetary health and the bioeconomy. Through perspectives from Human Health and Planetary Health investors and entrepreneurs, attendees will gain insight into how to translate scientific discoveries to an investable biotech company today.
Featured Speakers
Nanna Lüneborg PhD, MBA - General Partner, Human Health, Forbion
Joy Faucher - General Partner, Planetary Health, Forbion
Zahid Moneer, PhD, MBA - Head of Global Healthcare, Akur Capital
Ola Wlodek, PhD - CEO, Constructive Bio
Kathryn Chapman, PhD - Executive Director, Innovate Cambridge
Hanadi Jabado - Managing Partner, Sana Capital
Register your attendance here.